Health Catalyst delivered a strong performance in Q2 2025, with total revenue reaching $80.7 million and Adjusted EBITDA at $9.3 million, both surpassing the company's guidance. Despite a significant net loss, the company's core operational metrics showed positive growth.
Total revenue for Q2 2025 was $80.7 million, marking a 6% increase year-over-year.
Adjusted EBITDA reached $9.3 million in Q2 2025, a 24% increase compared to the same period last year.
The company reported a net loss of $40.978 million for the quarter, a significant increase from the prior year, primarily due to goodwill impairment.
Dan Burton, CEO, announced his plan to retire effective June 30, 2026, with a search for his successor underway.
For the third quarter of 2025, Health Catalyst expects total revenue of approximately $75 million and Adjusted EBITDA of approximately $10.5 million. For the full year 2025, total revenue is projected to be around $310 million, with Adjusted EBITDA at approximately $41 million.
Visualization of income flow from segment revenue to net income